Vinson B E, Schumacher G E
Am J Hosp Pharm. 1976 Nov;33(11):1164-6.
The ability of pharmacists and physicians to interpret and evaluate promotional and clinical bioavailability data was compared to that of a panel of scientists with experience in pharmacokinetics and pharmacology. An examination tested the ability of 18 physicians and 68 pharmacists to: (1) evaluate and make clinical decisions using promotional bioavailability data; (2) demonstrate the basic qualitative and quantitative skills needed to make rational judgments on drug product selection; and (3) distinguish between drugs with real or potential bioavailability problems. On the examination, pharmacists, as a group, scored significantly higher (52%) than physicians (35%), but the panelists scored highest (83%). Hospital pharmacists (61%) scored higher than community pharmacists (42%). Recommendations for future studies of this type are presented.
将药剂师和医生解读与评估促销及临床生物利用度数据的能力，与一组具有药代动力学和药理学经验的科学家的能力进行了比较。一项测试检验了18名医生和68名药剂师在以下方面的能力：(1) 使用促销生物利用度数据进行评估并做出临床决策；(2) 展示在合理选择药品方面做出理性判断所需的基本定性和定量技能；(3) 区分存在实际或潜在生物利用度问题的药物。在该测试中，药剂师作为一个群体的得分（52%）显著高于医生（35%），但小组成员得分最高（83%）。医院药剂师（61%）的得分高于社区药剂师（42%）。本文还给出了对此类未来研究的建议。
